Pre-solicitation Notice: On-Ramp for the Department of Defense OMNIBUS IV Multiple-Award Contract
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DEFENSE HEALTH AGENCY
Contract Value
Not provided
Codes & Classification
Solicitation Number
HT942626RE002
NAICS
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Classification Code
AN14
Additional Details
Documents1
The Defense Health Agency (DHA), operating under the Department of Defense, has issued a pre-solicitation notice regarding the On-Ramp for the OMNIBUS IV Multiple-Award Contract. This notice, identified by procurement number HT942626RE002, serves primarily as an amendment (0006) to redirect interested parties to a different Notice ID (HT942627RE002), as the solicitation for the OMNIBUS IV on-ramp was not posted under the FY2026 numbering. No further amendments will be issued under this notice ID, and contractors are advised to consult notices associated with HT942627RE002 for current and future information.
The OMNIBUS IV contract is classified under NAICS code 541714, which pertains to Research and Development in Biotechnology (except Nanobiotechnology), and carries the product service code AN14. The procurement is designated as an 8A set-aside, indicating that participation is limited to eligible small businesses under the Small Business Administration’s 8A program. This set-aside aims to foster opportunities for disadvantaged businesses within the federal contracting space.
The intended scope of the OMNIBUS IV contract encompasses research and development activities in biotechnology, excluding nanobiotechnology. While specific objectives and deliverables are not detailed in this notice, the classification suggests a focus on advancing biotechnological research relevant to defense health initiatives. Contractors should anticipate requirements related to scientific research, technology development, and potentially the application of biotechnological solutions to health and medical challenges faced by the Department of Defense.
The contracting entity is the Defense Health Agency, a federal office within the Department of Defense, responsible for managing health-related procurement and research. The primary point of contact for this opportunity is Jesse Nisley, who can be reached via email at [email protected] for further inquiries.
This notice remains active and is sourced from BIDMATCH_SAM, with additional information and attachments available through the official SAM.gov opportunity page (https://sam.gov/opp/c56ccad112fc49a89d4c1afdbef1ee15/view). Contractors interested in participating should review the referenced Notice ID (HT942627RE002) for the most current solicitation details and ensure alignment with the 8A set-aside requirements and the research and development focus in biotechnology.
In summary, this pre-solicitation notice is a procedural update directing contractors to the appropriate solicitation for the OMNIBUS IV on-ramp, which is expected to support the Defense Health Agency’s ongoing biotechnology research and development needs. Eligible 8A small businesses with relevant expertise are encouraged to monitor the updated notice for further instructions and requirements.